MRDVX | VIVIX | MRDVX / VIVIX | |
Total Expense Ratio | 1.22 | 0.04 | 3,050% |
Annual Report Gross Expense Ratio | 1.30 | 0.04 | 3,250% |
Fund Existence | 22 years | 27 years | - |
Gain YTD | 3.447 | -0.563 | -612% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.7B | 184B | 10% |
Annual Yield % from dividends | 1.64 | 2.35 | 70% |
Returns for 1 year | -3.42 | 4.70 | -73% |
Returns for 3 years | -0.84 | 21.55 | -4% |
Returns for 5 years | 21.56 | 72.85 | 30% |
Returns for 10 years | -11.98 | 97.55 | -12% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NANR | 53.85 | 0.76 | +1.43% |
SPDR S&P® North American Natural Res ETF | |||
CMF | 55.76 | 0.11 | +0.20% |
iShares California Muni Bond ETF | |||
HYGW | 30.56 | -0.03 | -0.11% |
iShares High Yld Crp Bd Buywrt Stgy ETF | |||
BBC | 17.28 | -0.27 | -1.54% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
CNBS | 17.19 | -0.88 | -4.88% |
Amplify Seymour Cannabis ETF |